Dariohealth chief medical officer omar manejwala, m.d., to present on the role of digital therapeutics in post-pandemic healthcare at dtx europe

New york , july 13, 2021 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced chief medical officer omar manejwala, m.d. will present "rebalancing: digital therapeutics in a post-pandemic healthcare system" during the virtual conference dtx europe on july 14 th at 5:55 a.m.
DRIO Ratings Summary
DRIO Quant Ranking